Early-stage Breast Cancer Clinical Trial
Official title:
Clinical Study of Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer
This is a prospective, single center, single-arm, phase IV study， to evaluate the effect of Huaier Granule on reducing the level of tumor markers in early-stage breast cancer patients.
This clinical trial is expected to include 379 patients in the follow-up stage after breast cancer surgery who visited the Breast Surgery Department of Fudan University Shanghai Cancer Hospital from October 2022 to October 2024. Excluding cases where tumor markers (CEA/CA125/CA153) exceed the normal upper limit level in the case of recurrence and metastasis. All participants received treatment with Huaier granules for 1 year, or experienced intolerable toxicity, withdrew from the study for any reason or died, whichever occurred first. The main research indicator is the recovery rate of tumor markers (CEA/CA125/CA153) to normal. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
| Completed |
NCT00165243 -
Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05559164 -
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
|
Phase 2 | |
| Completed |
NCT03948568 -
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
|
Phase 4 | |
| Recruiting |
NCT04553770 -
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT06001762 -
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03664687 -
Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)
|
Phase 4 | |
| Recruiting |
NCT04603209 -
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
|
||
| Completed |
NCT00233077 -
Patient Centered Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT02958033 -
Shandong Cancer Hospital Affiliated to Shandong University
|
Phase 3 | |
| Recruiting |
NCT03797248 -
Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer
|
||
| Recruiting |
NCT03788083 -
Intratumoral TriMix Injections in Early Breast Cancer Patients
|
Phase 1 | |
| Recruiting |
NCT05582499 -
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04003558 -
Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
|
||
| Terminated |
NCT03894007 -
Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT02982148 -
Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients
|
Phase 4 | |
| Active, not recruiting |
NCT03553797 -
Accelerated Whole Breast Irradiation Hypofractionation Plus Boost VS Standard Whole Breast Irradiation Plus Boost
|
Phase 3 | |
| Recruiting |
NCT06215469 -
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
|
N/A | |
| Enrolling by invitation |
NCT06409221 -
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
|
||
| Not yet recruiting |
NCT05280288 -
Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer
|
N/A |